All CAEP conference symposia are co-developed and are planned to achieve scientific integrity, objectivity and balance.

DOACs in AF and VTE patients in the ED
Sunday May 26th, 2019 from 07:00 – 08:15
Convention Hall C1

Speakers: Dr Peter Gross, Dr Jason Yung and Dr Indy Ghosh (Moderator)
Drs Gross, Yung and Ghosh will discuss the effectiveness and safety of NOACs for VTE treatment as well as recommendations on how to regiment anticoagulation for non-valvular Atrial Fibrillation patients undergoing cardioversion. This presentation will highlight how to manage anticoagulation in patients with different comorbidities.

Section 1: Nonvalvular Atrial Fibrillation Patients Undergoing Cardioversion
After participating in this program you will be able to:
1. Integrate the 2018 CCS Atrial Fibrillation (AF) Guidelines for Cardioversion
2. Consider the evidence guiding anticoagulation for cardioversion
3. Select appropriate anticoagulants for multimorbid patients

Section 2: Update on the Management of Venous Thromboembolism in the ED
After participating in this program you will be able to:
1. Consider multiple sources of evidence for the use of DOACs and VTE
2. Appropriately select anticoagulation Tx for different populations
3. Initiate oral anticoagulation when VTE is suspected

Hidradenitis Suppurativa: How to Recognize the Disease and When to Refer
Monday May 27th, 2019 from 07:00 – 08:15
Convention Hall C1

Speakers: Dr Irina Turchin and Dr Eugene Mah
Dr Turchin and Dr Mah will discuss how identifying Hidradenitis Suppurativa (HS) quickly in the ED plays a major role in preventing lesion recurrence. This presentation will highlight the referral of a patient with HS to a dermatological specialist and the resulting management plan.

Learning Objectives
After participating in this program you will be able to:
1. Recognize that Hidradenitis Suppurativa (HS) is a chronic, systemic, inflammatory condition requiring multi-disciplinary care beyond primary intervention
2. Identify HS in ED patients with recurrent acute episodes of inflamed lesions requiring I&D/pain relief
3. Distinguish between common skin conditions and that of HS which requires professional assessment and treatment of a dermatologist
4. Understand the burden of HS disease and the lengthy patient journey for HS patients

ED Doc as Master Diagnostician: Considering Rare Diseases in Patients with Repeat Visits
Tuesday May 28th, 2019 from 07:00 – 08:15
Convention Hall C1

Speakers: Dr Mark Korson and Dr Eddy Lang
Dr Korson and Dr Lang will discuss how identifying late or adult onset of rare genetic disorders such as acute intermittent porphyria can be difficult in the ED. This presentation will highlight the red flags that prompt us to initiate referrals for genetic assessment and further evaluation

Learning Objectives
After participating in this program you will be able to:
1. Identify those symptoms that suggest a “metabolic crisis”
2. Utilize those tests that can help characterize an acute metabolic disorder
3. Implement practical treatment strategies that can serve to stabilize a possible metabolic case
4. Develop a plan to get help when you suspect a patient with a possible or likely inborn error

Assessment and management of acute trauma-related pain in the ED
Tuesday May 28th, 2019 from 11:45 – 13:00
Convention Hall C1

Speakers: Dr David Flusk and Dr Ryan Henneberry
Dr Flusk and Dr Henneberry will discuss best practices for managing acute trauma-related pain in adults who present with pre-existing comorbid conditions. This presentation will evaluate the current and emerging treatment options for acute trauma-related pain and the essential components of the assessment and monitoring in the emergency department (ED).

Learning Objectives
After participating in this program you will be able to:
1. Define and implement essential components of the assessment and monitoring of acute trauma-related pain in the emergency department (ED)
2. Evaluate current and emerging treatment options for acute trauma-related pain in the ED
3. Identify best practices when managing acute trauma-related pain in adults with pre-existing comorbid conditions